When does INMED PHARMACEUTICALS INC (INM) report earnings?
INMED PHARMACEUTICALS INC (INM) will report earnings on 2026-05-11.
INMED PHARMACEUTICALS INC (INM) Forecast, Price Target & Analyst Ratings
NASDAQ:INM • CA4576377002
Current stock price
0.6804 USD
-0.01 (-2.06%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INMED PHARMACEUTICALS INC (INM).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $0.68 to mean target of N/A, Based on 8 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
45.00%
INM was analyzed by 8 analysts. The buy percentage consensus is at 45. So analysts seem to be rather negative about INM.
In the previous month the buy percentage consensus was at a similar level.
INM was analyzed by 8 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-11-29 | HC Wainwright & Co. | Initiate | Buy |
| 2021-02-16 | Roth Capital | Maintains | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 11, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 4.14M 279.82% | 4.598M 11.06% | 4.943M 7.50% | |
| EBITDA YoY % growth | -8.18M 38.96% | -7.915M 3.24% | -7.705M 2.65% | |
| EBIT YoY % growth | -8.38M 38.34% | -8.134M 2.93% | -7.918M 2.66% | |
| Operating Margin | -202.42% | -176.92% | -160.20% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A